Memorial hospital
Pulmonology
Dr. David S. Egilman, MD
|
|
Give Review
David Egilman is an expert in the field of Pulmonology. He went to Warren Alpert Medical School of Brown University. David Egilman is a published doctor. He has 81 publications published. The most current publication "Corruption of the medical literature: a second visit."
Publications
- Short fiber tremolite free chrysotile mesothelioma cohort revealed.
- Workers and consumers should not be exposed to chemicals that have not been tested for toxicity.
- Egilman's assessment regarding exposures of auto mechanics to amphiboles is correct.
- Study of Neurontin: Titrate to Effect, Profile of Safety (STEPS) Trial: A Narrative Account of a Gabapentin Seeding Trial.
- Corporate versus public interests: community responsibility to defend scientific integrity.
- A proposal for a safe exposure level for diacetyl.
- Deconstructing a State-of-the-Art Review of the Asbestos Brake Industry.
- Persistence of cardiovascular risk after rofecoxib discontinuation.
- Small is not necessarily beautiful.
- Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance.
- The ADVANTAGE seeding trial: a review of internal documents.
- Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
- IJOEH and the critique of bias.
- American College of Occupational and Environmental Medicine (ACOEM): a professional association in service to industry.
- Avoiding the regulatory capture of the Food and Drug Administration.
- Differential peeky bias.
- Report of specific cardiovascular outcomes of the ADVANTAGE trial.
- Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability.
- Chevron-Texaco's science.
- Over a barrel: corporate corruption of science and its effects on workers and the environment.
- Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation.
- Suppression bias at the Journal of Occupational and Environmental Medicine.
- Handling conflicts of interest between industry and academia.
- The beryllium "double standard" standard.
- MetLife and its corporate allies: dust diseases and the manipulation of science.
- Commentary on 'Evaluation of take home (para-occupational) exposure to asbestos and disease: a review of the literature', Donovan et al.1.
- The importance of scientific debate.
- P.W.J. Bartrip's attack on Irving J. Selikoff.
- Re: Controlled use of asbestos.
- Attorney-directed screenings can be hazardous.
- Texaco and its consultants.
- The asbestos TLV: early evidence of inadequacy.
- Re: Regulatory Toxicology and Pharmacology.
- Exposing the "myth" of ABC, "anything but chrysotile": a critique of the Canadian asbestos mining industry and McGill University chrysotile studies.
- Editorial policies on financial disclosure.
- Proving causation: the use and abuse of medical and scientific evidence inside the courtroom--an epidemiologist's critique of the judicial interpretation of the Dauber...
- Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry.
- Evidence for work-related musculoskeletal disorders.
- Lung cancer and asbestos exposure: asbestosis is not necessary.
- Costs and benefits of hepatitis prophylaxis.
- Long-term health effects following isocyanate exposure.
- Asbestos-related diseases.
- International exchange for medical training.
- International health needs.
- Ethics of mandatory masturbation.
- Corruption of occupational medical literature: the asbestos example.
- Anything but beryllium: the beryllium industry's corruption of safety information.
- Asbestos screenings.
- A little too much of the Buchenwald touch? Military radiation research at the University of Cincinnati, 1960-1972.
- Ethical aerobics: ACHRE's flight from responsibility.
- Corporate corruption of medical literature: asbestos studies concealed by W.R. Grace & Co.
- RE: Mesothelioma and lung tumors attributable to asbestos among petroleum workers. Am. J. Ind. Med. 2000. 37:275-282.
- Researchers should talk to workers.
- FIOH-sponsored newsletter misrepresents asbestos hazards in Zimbabwe.
- Corporate corruption of science--the case of chromium(VI).
- Manipulated data in Shell''s Benzene Historical Exposure Study.
- Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology.
- Popcorn-worker lung caused by corporate and regulatory negligence: an avoidable tragedy.
- Funding for primary health care in developing countries.
- Strengthening primary care: addressing the disparity between vertical and horizontal investment.
- Letter to U.S. FDA commissioner. Questions about the safety of the artificial sweetener aspartame.
- Call for global health-systems impact assessments.
- Fiber types, asbestos potency, and environmental causation: a peer review of published work and legal and regulatory scientific testimony.
- Ford, General Motors, Chrysler, asbestos, and a "sane appreciation of the risks".
- Beyond reputation: debate on the role of corporate influence in occupational and environmental medicine.
- Report of a recent "brake" through in the fiber burden-mesothelioma dialogue.
- Letter to the Editor regarding the Donovan et al. (2011) article.
- Gets AIDS and survive? The "perverse" effects of aid: addressing the social and environmental determinants of health, promoting sustainable primary care, and rethinkin...
- Medical schools in sub-Saharan Africa.
- An elaboration of "proof" of peritoneal mesothelioma from tremolite free chrysotile.
- A case of occupational peritoneal mesothelioma from exposure to tremolite-free chrysotile in Quebec, Canada: A black swan case.
- Scientists appeal to Quebec Premier Charest to stop exporting asbestos to the developing world.
- What have we learnt from Vioxx?
- Corruption of previously published asbestos research.
- Breast implant verdicts resulted from corporate misconduct and legitimate science.
- Corruption of the medical literature: a second visit.
- Public health and epistemology.
- Mesothelioma: An unwarranted causal model.
- Evaluating the health risks of breast implants.
- The origin and development of the asbestos Threshold Limit Value: scientific indifference and corporate influence.
Schools
Brown University Alpert Medical School
Carney Hospital
Nat39l Institute Occupational Safety
University Of Rochester
Doctors Specialties
- Internal Medicine
- Occupational Medicine
- Preventive Occupational Medicine
- Pulmonology
Accepted Insurances
Education
-
University of Rochester -
Warren Alpert Medical School of Brown University
Helpful Reviews
Similar Doctors
|
|
Dr. Mohammad A. Khan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
M P. Munoz |
|
|
Dr. Eleanor M. Summerhill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Franklin D. McCool, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda T. Nici, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick Weyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jigme M. Sethi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Amrita Desai, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mervat Saleh, MD |
|
Dr. Rodney P. Larcom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ahmad Daraghmeh, MD |
|
|
Dr. Richard A. Carleton, MD |
|
|
Dr. Joseph A. Diaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joyce Coppola, MD
This Doctor is OpenDoctor Recommended.
|